免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Revolution ACT

K号: K171013 · 2017-06-05

决定日期2017-06-05
产品代码JAK
咨询委员会RA
决定实质等同

器械摘要

Revolution ACT is the device name listed in this FDA 510(k) record. The listed applicant is Ge Hangwei Medical Systems Co., Ltd.. It received FDA 510(k) clearance on 2017-06-05 under 510(k) number K171013. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Revolution ACT?

Revolution ACT is a medical device that received FDA 510(k) clearance on 2017-06-05. The listed applicant is Ge Hangwei Medical Systems Co., Ltd.. The 510(k) number is K171013.

When did Revolution ACT receive FDA 510(k) clearance?

Revolution ACT received FDA 510(k) clearance on 2017-06-05, under 510(k) number K171013.

Who is the listed applicant for Revolution ACT?

The FDA 510(k) record lists Ge Hangwei Medical Systems Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Revolution ACT?

The FDA product code for Revolution ACT is JAK.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Ge Hangwei Medical Systems Co., Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:JAK)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑